Pharmaceutical major Cipla on Friday reported a 17.4 per cent jump in its consolidated net profit at Rs 1,178 crore for the first quarter of the current financial year 2024-25, compared with Rs 1,003 in the corresponding period last year. The results beat market expectations. Following this, the company surged Rs 90 or 6.1 per cent to Rs 1,590 apiece on the BSE.
The company’s consolidated income from operations during April-June 2024 rose 7 per cent to Rs 6,694 crore, against Rs 6,258 a year ago, according to a BSE filing.
Its Ebitda also jumped 13.8 per cent to Rs 1,716 per cent in Q1 FY25, compared with Rs 1,508 a year ago.
